• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.表现出矛盾性降低卡泊芬净敏感性但增加米卡芬净敏感性的光滑念珠菌突变体。
Antimicrob Agents Chemother. 2011 Aug;55(8):3947-9. doi: 10.1128/AAC.00044-11. Epub 2011 May 31.
2
CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction.光滑念珠菌中的 CRS-MIS:鞘脂类调节棘白菌素-Fks 相互作用。
Mol Microbiol. 2012 Oct;86(2):303-13. doi: 10.1111/j.1365-2958.2012.08194.x. Epub 2012 Aug 22.
3
Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.在光滑念珠菌临床分离株中检测到的高水平米卡芬净耐药性的重建,确定了葡聚糖合酶基因表达中的功能性纯合性。
J Antimicrob Chemother. 2012 Jul;67(7):1666-76. doi: 10.1093/jac/dks112. Epub 2012 Apr 18.
4
Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.通过体内药效学评估优化棘白菌素类药物剂量和敏感性折点判断方法,用于治疗有或无 fks 突变的光滑念珠菌感染。
Antimicrob Agents Chemother. 2012 Nov;56(11):5875-82. doi: 10.1128/AAC.01102-12. Epub 2012 Sep 4.
5
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.FKS 突变与美国基于人群监测的光滑念珠菌分离株中棘白菌素 MIC 值升高相关。
Antimicrob Agents Chemother. 2010 Dec;54(12):5042-7. doi: 10.1128/AAC.00836-10. Epub 2010 Sep 13.
6
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
7
Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.采用 CLSI 方法和解释标准,使用米卡芬净作为替代标志物,预测 3764 株临床分离念珠菌对卡泊芬净的敏感性和耐药性。
J Clin Microbiol. 2014 Jan;52(1):108-14. doi: 10.1128/JCM.02481-13. Epub 2013 Oct 23.
8
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响:对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
9
In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.体外暴露于不断增加的米卡芬净浓度很容易促进光滑念珠菌分离株对棘白菌素产生耐药性。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01542-16. Print 2017 Feb.
10
In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.光滑念珠菌对卡泊芬净的体外抗真菌药敏性以及FKS基因突变的存在与侵袭性感染免疫受损小鼠模型中的治疗反应相关。
Antimicrob Agents Chemother. 2014 Jul;58(7):3646-9. doi: 10.1128/AAC.02666-13. Epub 2014 Apr 14.

引用本文的文献

1
Ergosterol-depleted clinical isolates of can develop multi-drug resistance without apparent fitness and virulence defects.麦角固醇缺乏的临床分离株可产生多重耐药性,且无明显的适应性和毒力缺陷。
bioRxiv. 2025 Aug 28:2025.08.28.672802. doi: 10.1101/2025.08.28.672802.
2
Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure.由于非整倍体而适应卡泊芬净的菌株在持续的药物压力下变得高度耐受。
Microorganisms. 2022 Dec 21;11(1):23. doi: 10.3390/microorganisms11010023.
3
Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.白念珠菌多个基因影响棘白菌素适应突变株的敏感性。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0097722. doi: 10.1128/aac.00977-22. Epub 2022 Nov 10.
4
Echinocandin Resistance in Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions.棘白菌素耐药性对影响药物-靶点相互作用的膜脂质扰动具有广泛影响。
Microbiol Insights. 2019 Dec 31;12:1178636119897034. doi: 10.1177/1178636119897034. eCollection 2019.
5
Emergence of resistant in Germany.德国耐药性的出现。
JAC Antimicrob Resist. 2021 Aug 7;3(3):dlab122. doi: 10.1093/jacamr/dlab122. eCollection 2021 Sep.
6
The role of aneuploidy in the emergence of echinocandin resistance in human fungal pathogen Candida albicans.非整倍体在人类真菌病原体白色念珠菌棘白菌素耐药性产生中的作用。
PLoS Pathog. 2021 May 27;17(5):e1009564. doi: 10.1371/journal.ppat.1009564. eCollection 2021 May.
7
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).指南:外阴阴道假丝酵母菌病(AWMF 015/072,S2k 级别)。
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
8
Pan-Echinocandin-Resistant Bloodstream Infection Complicating COVID-19: A Fatal Case Report.泛棘白菌素耐药血流感染并发新型冠状病毒肺炎:一例死亡病例报告
J Fungi (Basel). 2020 Sep 6;6(3):163. doi: 10.3390/jof6030163.
9
Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.应激诱导β-(1,3)-d-葡聚糖合酶的脂微环境改变导致烟曲霉产生临床重要的棘白菌素类耐药性。
mBio. 2019 Jun 4;10(3):e00779-19. doi: 10.1128/mBio.00779-19.
10
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.

本文引用的文献

1
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.重新审视棘白菌素类药物和念珠菌的临床折点:整合分子、临床和微生物学数据,以制定出基于物种的解释标准。
Drug Resist Updat. 2011 Jun;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. Epub 2011 Feb 24.
2
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.利用流行病学截断值来检测 9 年来念珠菌属对安尼鲁单抗、卡泊芬净和米卡芬净敏感性的变化趋势。
J Clin Microbiol. 2011 Feb;49(2):624-9. doi: 10.1128/JCM.02120-10. Epub 2010 Dec 8.
3
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.FKS 突变与美国基于人群监测的光滑念珠菌分离株中棘白菌素 MIC 值升高相关。
Antimicrob Agents Chemother. 2010 Dec;54(12):5042-7. doi: 10.1128/AAC.00836-10. Epub 2010 Sep 13.
4
Breakthrough invasive candidiasis in patients on micafungin.米卡芬净治疗患者发生突破性侵袭性念珠菌病。
J Clin Microbiol. 2010 Jul;48(7):2373-80. doi: 10.1128/JCM.02390-09. Epub 2010 Apr 26.
5
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.全球范围内念珠菌菌株的 fks1 热点 1 突变低流行率。
Antimicrob Agents Chemother. 2010 Jun;54(6):2655-9. doi: 10.1128/AAC.01711-09. Epub 2010 Apr 5.
6
Novel FKS mutations associated with echinocandin resistance in Candida species.新型 FKS 突变与棘白菌素类耐药的念珠菌属相关。
Antimicrob Agents Chemother. 2010 May;54(5):2225-7. doi: 10.1128/AAC.00998-09. Epub 2010 Feb 9.
7
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响:对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
8
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南:美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
9
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.念珠菌血症治疗期间因FKS1突变导致光滑念珠菌敏感性降低。
Antimicrob Agents Chemother. 2008 Jun;52(6):2263-5. doi: 10.1128/AAC.01568-07. Epub 2008 Mar 31.
10
Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection.采用种特异性PCR检测法对不同年龄组女性阴道菌群念珠菌属分离株进行调查。
J Clin Microbiol. 2008 Apr;46(4):1501-3. doi: 10.1128/JCM.02485-07. Epub 2008 Feb 27.

表现出矛盾性降低卡泊芬净敏感性但增加米卡芬净敏感性的光滑念珠菌突变体。

Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.

机构信息

Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19129, USA.

出版信息

Antimicrob Agents Chemother. 2011 Aug;55(8):3947-9. doi: 10.1128/AAC.00044-11. Epub 2011 May 31.

DOI:10.1128/AAC.00044-11
PMID:21628537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3147630/
Abstract

Echinocandins, including caspofungin (CSP) and micafungin (MCF), are highly active versus Candida glabrata (MIC of ≤0.06 μg/ml). True resistance (MIC of ≥1 μg/ml) is a rare event and strictly associated with mutations in β-1,3-glucan synthase gene FKS1 or FKS2. In contrast, we show here that mutants exhibiting reduced susceptibility to CSP (CRS; MICs of 0.12 to 0.5 μg/ml) are readily selected in vitro and, paradoxically, demonstrate increased susceptibility to MCF (MIS) ranging from 4- to 32-fold. CRS-MIS mutants were generated from all 10 C. glabrata strains tested and were tentatively identified within a collection of clinical isolates. Intriguingly, sequencing and gene disruption demonstrated that CRS-MIS is Fks independent.

摘要

棘白菌素类,包括卡泊芬净(CSP)和米卡芬净(MCF),对光滑念珠菌(MIC≤0.06μg/ml)具有高度活性。真正的耐药(MIC≥1μg/ml)是一种罕见的事件,并且与β-1,3-葡聚糖合成酶基因 FKS1 或 FKS2 的突变密切相关。相比之下,我们在这里表明,对 CSP 表现出降低敏感性的突变体(CRS;MIC 值为 0.12 至 0.5μg/ml)在体外很容易被选择,并且矛盾的是,对 MCF(MIS)的敏感性增加了 4 至 32 倍。CRS-MIS 突变体是从所有 10 株测试的光滑念珠菌菌株中产生的,并在一组临床分离株中被初步鉴定。有趣的是,测序和基因敲除表明 CRS-MIS 与 Fks 无关。